| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3826905 | Progrès en Urologie | 2010 | 11 Pages |
Abstract
The first results of the use of IPDE 5 in the LUTS treatment secondary to the HBP seem promising. However, a direct comparison of efficacy of IPDE 5 and alpha-blockers or 5-alpha-reductase inhibitors is not yet available. The mechanism(s) of action(s) of these compounds in this indication remain difficult to affirm even if new hypotheses can be formulated.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
R. Caremel, S. Oger-Roussel, D. Behr-Roussel, P. Grise, F. Giuliano,